Do the patients in insulin analogues use via judicial action have adequate metabolic control?

Vol. 1, 2019. - 117946
Pôster
Favorite this paper
How to cite this paper?
Abstract

Among the drugs most commonly used in judicial actions, are those used to treat diabetes mellitus, especially insulin therapy1,2. This study aimed to verify the metabolic control of fasting glucose and glycated hemoglobin in patients with type 1 diabetes mellitus (DM1) in judicialization of health, which use insulin analogues. 89 patients with DM1 acquire insulin analogues by judicialization of health in Divinópolis-MG. 43 (48.31%) participated in the study and underwent laboratory tests of fasting glucose and glycated hemoglobin levels.
53,5% were women and 72,1% used the ultra-fast insulin “aspart”. The average of the fasting glucose was 174,75 mg/dL ±70,33 and the glycated hemoglobin 8,68% ±1,65, revealing 74,4% and 88,37% patients with levels higher than those recommended, > 130 mg/dL e > 7% respectively.
It is observed that the patients in insulin analogues use, via judicial action, don’t have adequate metabolic control of DM1.

Institutions
  • 1 Universidade Federal de São João del-Rei (UFSJ)
Track
  • Pharmaceutical Care
Keywords
Diabetes mellitus type 1
insulin
Health's Judicialization